PARK7 and Parkinson disease: In 6-OHDA and MPTP-induced PD mouse models, as well as in transgenic mouse models (hA35T α-syn), PBT434 can prevent the loss of neurons in the SN and reduce α-syn accumulation by lowering oxidative damage markers such as H2O2 and increasing the levels of FPN and DJ-1 [67].